Back
Fulcrum Therapeutics Vs. Bioventus Industry Stock Comparison
Sell
40
FULC
Fulcrum Therapeutics
Last Price:
3.48
Seasonality Move:
85.55%
Buy
99
BVS
Bioventus
Last Price:
11.03
Seasonality Move:
-26.38%
Sell
40
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy, Sell or Hold?
- The current Fulcrum Therapeutics [FULC] share price is $3.44. The Score for FULC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- FULC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
99
Bioventus (BVS)
is a Buy
Is Bioventus a Buy, Sell or Hold?
- The current Bioventus [BVS] share price is $11.27. The Score for BVS is 99, which is 98% above its historic median score of 50, and infers lower risk than normal.
- BVS is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
FULC Stock Price Chart
What is Fulcrum Therapeutics's stock price today?
-
The Fulcrum Therapeutics share price today is $3.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing buying pressure, which is a positive indicator for future bullish movement.
BVS Stock Price Chart
FULC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 43.09 | Sell |
| Chaikin Money Flow: | 1011197 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.23 - 3.63) | Buy |
| Bollinger Bands (100): | (3.84 - 8.74) | Sell |
BVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 37.55 | Sell |
| Chaikin Money Flow: | -412922 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.67 - 13.37) | Sell |
| Bollinger Bands (100): | (6.77 - 11.95) | Buy |
FULC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.26 | Buy |
| 20-day SMA: | 3.36 | Buy |
| 50-day SMA: | 4.57 | Sell |
| 200-day SMA: | 7.42 | Sell |
| 8-day EMA: | 3.31 | Buy |
| 20-day EMA: | 3.46 | Sell |
| 50-day EMA: | 4.48 | Sell |
| 200-day EMA: | 6.32 | Sell |
BVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.94 | Sell |
| 20-day SMA: | 12.76 | Sell |
| 50-day SMA: | 11.66 | Sell |
| 200-day SMA: | 7.26 | Buy |
| 8-day EMA: | 12.6 | Sell |
| 20-day EMA: | 12.59 | Sell |
| 50-day EMA: | 11.55 | Sell |
| 200-day EMA: | 8.14 | Buy |
Fulcrum Therapeutics Earnings Growth & FULC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and a decrease next year of $0.78 per share.
Bioventus Earnings Growth & BVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $0.25 per share.
Fulcrum Therapeutics Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bioventus Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||